BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38491013)

  • 21. Postnatal liver functional maturation requires Cnot complex-mediated decay of mRNAs encoding cell cycle and immature liver genes.
    Suzuki T; Kikuguchi C; Nishijima S; Nagashima T; Takahashi A; Okada M; Yamamoto T
    Development; 2019 Feb; 146(4):. PubMed ID: 30733279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CCR4-NOT deadenylase complex controls Atg7-dependent cell death and heart function.
    Yamaguchi T; Suzuki T; Sato T; Takahashi A; Watanabe H; Kadowaki A; Natsui M; Inagaki H; Arakawa S; Nakaoka S; Koizumi Y; Seki S; Adachi S; Fukao A; Fujiwara T; Natsume T; Kimura A; Komatsu M; Shimizu S; Ito H; Suzuki Y; Penninger JM; Yamamoto T; Imai Y; Kuba K
    Sci Signal; 2018 Feb; 11(516):. PubMed ID: 29438013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and assembly of the NOT module of the human CCR4-NOT complex.
    Boland A; Chen Y; Raisch T; Jonas S; Kuzuoğlu-Öztürk D; Wohlbold L; Weichenrieder O; Izaurralde E
    Nat Struct Mol Biol; 2013 Nov; 20(11):1289-97. PubMed ID: 24121232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype.
    Cejas P; Cavazza A; Yandava CN; Moreno V; Horst D; Moreno-Rubio J; Burgos E; Mendiola M; Taing L; Goel A; Feliu J; Shivdasani RA
    Cancer Res; 2017 Feb; 77(3):766-779. PubMed ID: 27899379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipocyte-specific disruption of mouse Cnot3 causes lipodystrophy.
    Li X; Morita M; Kikuguchi C; Takahashi A; Suzuki T; Yamamoto T
    FEBS Lett; 2017 Jan; 591(2):358-368. PubMed ID: 28032897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-MYC regulates cell survival via eIF4G1 in inv(16) acute myeloid leukemia.
    Peramangalam PS; Surapally S; Veltri AJ; Zheng S; Burns R; Zhu N; Rao S; Muller-Tidow C; Bushweller JH; Pulikkan JA
    Sci Adv; 2024 Mar; 10(9):eadh8493. PubMed ID: 38416825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
    Shi X; Yang Y; Shang S; Wu S; Zhang W; Peng L; Huang T; Zhang R; Ren R; Mi J; Wang Y
    BMC Cancer; 2019 Nov; 19(1):1072. PubMed ID: 31703632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCR4-NOT differentially controls host versus virus poly(a)-tail length and regulates HCMV infection.
    Burgess HM; Grande R; Riccio S; Dinesh I; Winkler GS; Depledge DP; Mohr I
    EMBO Rep; 2023 Dec; 24(12):e56327. PubMed ID: 37846490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.
    Leong WZ; Tan SH; Ngoc PCT; Amanda S; Yam AWY; Liau WS; Gong Z; Lawton LN; Tenen DG; Sanda T
    Genes Dev; 2017 Dec; 31(23-24):2343-2360. PubMed ID: 29326336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synonymous codon usage regulates translation initiation.
    Barrington CL; Galindo G; Koch AL; Horton ER; Morrison EJ; Tisa S; Stasevich TJ; Rissland OS
    Cell Rep; 2023 Dec; 42(12):113413. PubMed ID: 38096059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of mRNA fate by the human Ccr4-Not complex is driven by coding sequence composition and mRNA localization.
    Gillen SL; Giacomelli C; Hodge K; Zanivan S; Bushell M; Wilczynska A
    Genome Biol; 2021 Oct; 22(1):284. PubMed ID: 34615539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CNOT3 contributes to early B cell development by controlling Igh rearrangement and p53 mRNA stability.
    Inoue T; Morita M; Hijikata A; Fukuda-Yuzawa Y; Adachi S; Isono K; Ikawa T; Kawamoto H; Koseki H; Natsume T; Fukao T; Ohara O; Yamamoto T; Kurosaki T
    J Exp Med; 2015 Aug; 212(9):1465-79. PubMed ID: 26238124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of β-cell identity and diabetic phenotype in mice caused by disruption of CNOT3-dependent mRNA deadenylation.
    Mostafa D; Yanagiya A; Georgiadou E; Wu Y; Stylianides T; Rutter GA; Suzuki T; Yamamoto T
    Commun Biol; 2020 Aug; 3(1):476. PubMed ID: 32859966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal Ago-binding domain of GW182 contains a tryptophan-rich region that confer binding to the CCR4-NOT complex.
    Wakiyama M; Takimoto K
    Genes Cells; 2022 Sep; 27(9):579-585. PubMed ID: 35822830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cnot1, Cnot2, and Cnot3 maintain mouse and human ESC identity and inhibit extraembryonic differentiation.
    Zheng X; Dumitru R; Lackford BL; Freudenberg JM; Singh AP; Archer TK; Jothi R; Hu G
    Stem Cells; 2012 May; 30(5):910-22. PubMed ID: 22367759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors.
    Altman JK; Sassano A; Kaur S; Glaser H; Kroczynska B; Redig AJ; Russo S; Barr S; Platanias LC
    Clin Cancer Res; 2011 Jul; 17(13):4378-88. PubMed ID: 21415215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.
    Placke T; Faber K; Nonami A; Putwain SL; Salih HR; Heidel FH; Krämer A; Root DE; Barbie DA; Krivtsov AV; Armstrong SA; Hahn WC; Huntly BJ; Sykes SM; Milsom MD; Scholl C; Fröhling S
    Blood; 2014 Jul; 124(1):13-23. PubMed ID: 24764564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia.
    Tamburini J; Green AS; Bardet V; Chapuis N; Park S; Willems L; Uzunov M; Ifrah N; Dreyfus F; Lacombe C; Mayeux P; Bouscary D
    Blood; 2009 Aug; 114(8):1618-27. PubMed ID: 19458359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia.
    Yang E; Guan W; Gong D; Gao X; Han C; Zhang J; Wang H; Wang M; Li Y; Yu L
    Clin Sci (Lond); 2020 Dec; 134(23):3079-3091. PubMed ID: 33201243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.